Itonis Inc (ITNS)
Itonis, Inc. is an OTC Markets-listed common stock issuer in the healthcare sector, with a focus on pharmaceuticals. The company is a development-stage business that seeks to produce and market over-the-counter and prescription homeopathic preparations for common ailments and chronic conditions. Its product efforts have included Emesyl, which is intended for the relief of mild to moderate nausea, and the company has placed a manufacturing order for the first batch of that product line. Formerly known as Kenshou, Inc., the company adopted the Itonis, Inc. name in December 2005. It was founded in 2005 and is headquartered in Laguna Hills, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ITNS
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
609.363 K
|
—
|
—
|
—
|
—
|
—
|
—
|